DWV
ANGLE plc
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Diagnostics & Research
Industry
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer.
Similar securities
Based on sector and market capitalization
Report issue